Formed in late 2004, Codon Devices is still a relative newcomer to the field. But that hasn’t stopped it from shooting to be a leader in the gene synthesis industry — and with a recent deal with ag biotech Agrivida under its belt, the startup is certainly taking steps toward that goal.

With co-founders including George Church, Drew Endy, Jay Keasling, and Joseph Jacobson, it’s no wonder Codon already has a bevy of customers and has also played a critical role in trying to shape the education and regulatory environment surrounding gene synthesis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.